Figures and data
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_tbl1.tif/full/max/0/default.jpg)
Results were analyzed using unpaired T-test with Welch’s correction. Results are presented as median and percentiles (25th and 75th).
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_tbl2.tif/full/max/0/default.jpg)
Results were analyzed using unpaired T-test with Welch’s correction and are presented as median and percentiles (25th and 75th).
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_tbl3.tif/full/max/0/default.jpg)
Results were analyzed using unpaired T-test with Welch’s correction and are presented as median and percentiles (25th and 75th).
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_fig1.tif/full/max/0/default.jpg)
Gene expression analysis in trabecular bone samples. (A) SOST mRNA levels resulted higher in T2D subjects versus Nondiabetic subjects (p<0.0001). (B) DKK-1 mRNA expression level was not different between groups (p=0.2022). (C) LEF-1 mRNA levels resulted lower in T2D subjects versus nondiabetics subjects (p=0.0136). (D) WNT10B mRNA expression level was lower in T2D subjects versus nondiabetic subjects (p=0.0302). (E) WNT5A mRNA resulted higher in T2D subjects versus nondiabetics subjects (p=0.0232). (F) COL1A1 mRNA levels resulted lower in T2D subjects versus Nondiabetic subjects (p=0.0482). (G) GSK3B mRNA levels resulted higher in T2D subjects versus Nondiabetic subjects (p=0.0456). (H-J) AXIN2, BETA-CATENIN, SFRP5 mRNA levels were not different between groups (p=0.2296, p=0.3073; p=0.1390). Data are expressed as fold changes over beta-actinMedians and interquartile ranges, differences between non-diabetics and T2D subjects were analyzed using Mann-Whitney test.
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_fig2.tif/full/max/0/default.jpg)
Relationship between AGEs (µg quinine/g collagen) bone content and mRNA level of the Wnt signaling key genes in T2D and non-diabetic subjects. (A) LEF-1 negatively correlated with AGEs (r=-0.7500; p=0.0255). (B) COL1A1 negatively correlated with AGEs (r=-0.9762; p=0.0004). (C) SOST mRNA level expression positively correlated with AGEs (r=0.9231; p<0.0001). (D) WNT5A mRNA expression level positively correlated with AGEs (r=0.6751; p=0.0322). (E) WNT10B mRNA expression level was not correlated with AGEs (r=-0.4883; p=0.1938). (F) DKK1 mRNA expression level was not correlated with AGEs (r=0.0476; p=0.9349). (G) GSK3B mRNA expression level was positively correlated with AGEs (r=0.7500; p=0.0255). (H) SFRP5 mRNA expression level was positively correlated with AGEs (r=0.7167; p=0.0369). (I) AXIN2 and (J) SFRP5 mRNA expression levels were not correlated with AGEs (r=0.5500, p=0.1328; r=0.2167, p=0.5809). Data were analyzed using nonparametric Spearman correlation analysis and r represents the correlation coefficient.
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_fig3.tif/full/max/0/default.jpg)
Relationship between fasting glucose levels (mg/dl) and disease duration with SOST and WNT5A mRNA levels. (A) SOST positively correlated with fasting glucose levels (r=0.4846; p=0.0043). (B) SOST positively correlated with disease duration (r=0.7107; p=0.0174). (C) WNT5A positively correlated with fasting glucose levels (r=0.5589; p=0.0037). (D) GSK3B positively correlated with fasting glucose levels (r=0.4901; p=0.0051). Data were analyzed using nonparametric Spearman correlation analysis and r represents the correlation coefficient.
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_fig4.tif/full/max/0/default.jpg)
Relationship between Young Modulus (MPa), Ultimate strength (MPa) and Yield strength (MPa) with mRNA levels of the Wnt signaling key genes in T2D and non-diabetic subjects. (A) SOST negatively correlated with Young Modulus (MPa); (r=-0.5675; p=0.0011). (B) LEF-1 positively correlated with Young Modulus (MPa); (r=0.4116; p=0.0295). (C) WNT10B positively correlated with Young Modulus (MPa); (r=0.6697; p=0.0001). (D) AXIN2 negatively correlated with Young Modulus (MPa); (r=-0.5523; p=0.0042). (E) BETA-CATENIN negatively correlated with Young Modulus (MPa); (r=-0.5244; p=0.0050). (F) SFRP5 negatively correlated with Young Modulus (MPa); (r=-0.4442; p=0.0437). (G) WNT10B positively correlated with Ultimate strength (MPa); (r=0.5392; p=0.0054). (H) AXIN2 negatively correlated with Ultimate strength (MPa); (r=-0.4180; p=0.0472). (I) BETA-CATENIN negatively correlated with Ultimate strength (MPa); (r=-0.5528; p=0.0034). (J) LEF-1 positively correlated with Yield strength (MPa); (r=0.4338; p=0.0495). (K) WNT10B positively correlated with Yield strength (MPa); (r=0.6632; p=0.0020). (L) GSK3B negatively correlated with Yield strength (MPa); (r=-0.4674; p=0.0245). (M) AXIN2 negatively correlated with Yield strength (MPa); (r=-0.5067; p=0.0319). (N) BETA-CATENIN negatively correlated with Yield strength (MPa); (r=-0.5491; p=0.0149). (O) SFRP5 negatively correlated with Yield strength (MPa); (r=-0.5357; p=0.0422). Data were analyzed using nonparametric Spearman correlation analysis and r represents the correlation coefficient.
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_figs1.tif/full/max/0/default.jpg)
Relationship between fasting glucose levels (mg/dl) and LEF-1, WNT5A, WNT10B, DKK-1, COL1A1 mRNA levels. (A-E) Data showed negative correlations between fasting glucose levels (mg/dl) and (A) LEF-1 (r=-0.3649; p=0.0613), (B) WNT10B (r=-0.0041; p=0.9863), (C) COL1A1 (r=-0.1157; p=0.5354), (D) DKK-1 (r=-0.0947; p=0.6522) mRNA levels. Data showed positive correlations between fasting glucose levels (mg/dl) with (E) AXIN2 (r=0.0993; p=0.6442), (F) BETA-CATENIN (r=0.2371; p=0.1991) and (G) SFRP5 (r=0.3767; p=0.0696). Data were analyzed using nonparametric Spearman correlation analysis and r represents the correlation coefficient.
![](https://prod--epp.elifesciences.org/iiif/2/90437%2Fv2%2Fcontent%2F23296647v2_figs2.tif/full/max/0/default.jpg)
Relationship between Young Modulus (MPa), Ultimate strength (MPa) and Yield strength (MPa) with mRNA levels of the Wnt signaling genes in T2D and non-diabetic subjects. (A) DKK-1 positively correlated with Young Modulus (MPa); (r=0.02857; p=0.9022). (B) COL1A1 positively correlated with Young Modulus (MPa); (r=0.2991; p=0.1397). (C) GSK3B negatively correlated with Young Modulus (MPa); (r=-0.3127; p=0.0814). (D) SOST negatively correlated with Ultimate strength (MPa); (r=-0.1468; p=0.4001). (E) DKK-1 negatively correlated with Ultimate strength (MPa); (r=0.1353; p=0.5694). (F) LEF-1 positively correlated with Ultimate strength (MPa); (r=0.2790; p=0.1588). (G) WNT5A negatively correlated with Ultimate strength (MPa); (r=-0.0143; p=0.9469). (H) COL1A1 positively correlated with Ultimate strength (MPa); (r=0.2138; p=0.3047). (I) GSK3B negatively correlated with Ultimate strength (MPa); (r=-0.3482; p=0.0594). (J) SFPR5 negatively correlated with Ultimate strength (MPa); (r=-0.3789; p=0.0994). (K) SOST positively correlated with Yield strength (MPa); (r=0.1009; p=0.6390). (L) DKK-1 positively correlated with Yield strength (MPa); (r=0.2786; p=0.3139). (M) WNT10B negatively correlated with Yield strength (MPa); (r=-0.0079; p=0.9744). (N) COL1A1 positively correlated with Yield strength (MPa); (r=0.2196; p=0.3260). (O) BETA-CATENIN negatively correlated with Young Modulus strength (MPa); (r=-0.1667; p=0.4953). (P) BETA-CATENIN negatively correlated with Ultimate strength (MPa); (r=-0.2797; p=0.2610). (Q) BETA-CATENIN negatively correlated with Yield strength (MPa); (r=-0.1813; p=0.5537). Data were analyzed using nonparametric Spearman correlation analysis and r represents the correlation coefficient.